GlassScriptPhysician profile
Danny Sanovich
NPI 1124476635
$4,049.23
in general payments reported to CMS, 2019-2025
15 companies · $512 in 2025
The $512 reported for 2025 was more than what 78% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
See the full distribution for Oral and Maxillofacial Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,819 · 2020: $479 · 2021: $338 · 2022: $382 · 2023: $131 · 2024: $387 · 2025: $512.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,031.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,030.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $2,106.99 | 2019-2020 | |
| Kls-Martin L.P. | $449.63 | 2020-2025 | |
| Straumann USA LLC | $361.56 | 2022-2025 | |
| Allergan, INC. | $311.82 | 2021-2022 | |
| Geistlich Pharma, North America, INC. | $265.83 | 2020-2025 | Bio-Gide |
| Depuy Synthes Sales INC. | $192.91 | 2024 | Trumatch |
| Abbvie INC. | $87.20 | 2023-2024 | Botox |
| Stryker Corporation | $68.08 | 2021 | |
| Galderma Laboratories, L.P. | $62.33 | 2021-2025 | |
| Philips North America LLC | $39.10 | 2022 | |
| Zimmer Biomet Holdings, INC. | $36.00 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $22.00 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $20.41 | 2023 | Exparel |
| Ethicon US, LLC | $13.27 | 2024 | Surgiflo Hemostatic Matrix |
| Nobel Biocare USA | $12.10 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danny Sanovich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.